Literature DB >> 14999605

Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure?

Mitzi G Mendonça1, Maria E F de Brito, Eduardo H G Rodrigues, Valdir Bandeira, Márcio L Jardim, Frederico G C Abath.   

Abstract

BACKGROUND: It is uncertain whether Leishmania parasites ever disappear after clinical cure of American cutaneous leishmaniasis (ACL). Recently, sensitive molecular techniques have allowed the identification of Leishmania parasites directly in specimens from patients' scars.
METHODS: Scars of 32 patients from northeastern Brazil who were treated and clinically cured of ACL were analyzed by use of polymerase chain reaction (PCR), culture, and histopathologic examination.
RESULTS: DNA specific for Leishmania (Viannia) was detected in scars of 30 (93.7%) of 32 patients. In specimens from 3 of the scars, Leishmania parasites could be isolated by culture; PCR results also were positive for those 3 specimens. No parasites were found by histopathologic examination, and fibrotic alterations were present in all cases, with slight inflammatory foci observed in 4 of the cases studied.
CONCLUSIONS: The results suggest that clinical cure of ACL is rarely associated with sterile cure. The implications of persistence of parasites for the clinical evolution, relapse, and transmission of leishmaniasis deserves further studies, particularly with the increasing incidence of coinfection with leishmaniasis and acquired immunodeficiency syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999605     DOI: 10.1086/382135

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  68 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Endemic tegumentary leishmaniasis in Brazil: correlation between level of endemicity and number of cases of mucosal disease.

Authors:  Sandro J Bedoya-Pacheco; Maria H Araujo-Melo; Claudia M Valete-Rosalino; Maria Inês F Pimentel; Fátima Conceição-Silva; Armando O Schubach; Mauro C A Marzochi
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

3.  Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.

Authors:  Tatiana R de Moura; Fernanda O Novais; Fabiano Oliveira; Jorge Clarêncio; Almério Noronha; Aldina Barral; Claudia Brodskyn; Camila I de Oliveira
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Quantitative nucleic acid sequence-based assay as a new molecular tool for detection and quantification of Leishmania parasites in skin biopsy samples.

Authors:  Wendy F van der Meide; Gerard J Schoone; William R Faber; Jim E Zeegelaar; Henry J C de Vries; Yusuf Ozbel; Rudy F M Lai A Fat; Leíla I A R C Coelho; Masoom Kassi; Henk D F H Schallig
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

5.  Recent Developments in Leishmaniasis: Epidemiology, Diagnosis, and Treatment.

Authors:  Jonathan Berman
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.725

6.  A nanodiagnostic colorimetric assay for 18S rRNA of Leishmania pathogens using nucleic acid sequence-based amplification and gold nanorods.

Authors:  Alireza Niazi; Oghol-Niaz Jorjani; Hassan Nikbakht; Pooria Gill
Journal:  Mol Diagn Ther       Date:  2013-12       Impact factor: 4.074

7.  Eligibility for Local Therapies in Adolescents and Adults with Cutaneous Leishmaniasis from Southwestern Colombia: A Cross-Sectional Study.

Authors:  Andrés Felipe Uribe-Restrepo; Miguel Dario Prieto; Alexandra Cossio; Mayur M Desai; María Del Mar Castro
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

8.  Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment.

Authors:  Luiza C Reis; Maria Edilenza F Brito; Marina A Souza; Angela C R Medeiros; Claudio J Silva; Carlos F Luna; Valéria R A Pereira
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

9.  A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection.

Authors:  Naomi E Aronson; Glenn W Wortmann; William R Byrne; Robin S Howard; Wendy B Bernstein; Mary A Marovich; Mark E Polhemus; In-Kyu Yoon; Kelly A Hummer; Robert A Gasser; Charles N Oster; Paul M Benson
Journal:  PLoS Negl Trop Dis       Date:  2010-03-09

10.  Recurrent American cutaneous leishmaniasis.

Authors:  Jean-Pierre Gangneux; Sylvie Sauzet; Sébastien Donnard; Nicolas Meyer; Anne Cornillet; Francine Pratlong; Claude Guiguen
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.